| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | Brazil | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | African Regional Industrial Property Organization | 2 | |
| #5 | South Africa | 2 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Jordan | 1 | |
| #9 | Luxembourg | 1 | |
| #10 | Philippines | 1 | |
| #11 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Syringes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Betageri Guru V | 12 |
| #2 | Venkatesan Natarajan | 8 |
| #3 | Thirucote Ramachandran | 8 |
| #4 | Guru V Betageri | 5 |
| #5 | Kadajji Veeran Gowda | 5 |
| #6 | Ramachandran Thirucote | 4 |
| #7 | Oefelein Michael G | 4 |
| #8 | Oefelein Michael | 3 |
| #9 | Betageri Guru | 3 |
| #10 | Michael G Oefelein | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021030260A1 | Proliposomal testosterone undecanoate formulations | |
| WO2020093044A1 | Liposomal enhanced intra-peritoneal chemotherapy | |
| WO2019018619A1 | Liposomal paclitaxel formulation for treating bladder cancer | |
| AU2017358049A1 | Methods of treating upper tract urothelial carcinomas | |
| CN109276540A | For treating the liposomal paclitaxel formulation of bladder cancer | |
| JO3810B1 | Proliposomal testosterone formulations |